January 2009, Vol 2, No 1

Business

Prescription Copay Reduction Program for Diabetic Employees: Impact on Medication Compliance and Healthcare Costs and Utilization
Kavita V. Nair, PhD
; Kerri Miller, PharmD, BCPS
; Joseph Saseen, PharmD, FCCP, BCPS
; Pamela Wolfe, MS
; Richard Read Allen, MS
; Jinhee Park, CPhil, MA, MS
Stakeholder Perspective by Geoffrey P. Cole, MD, MBA

Clinical

Partial Compliance with Antipsychotics Increases Mental Health Hospitalizations in Schizophrenic Patients: Analysis of a National Managed Care Database
Chris M. Kozma, PhD
; Peter J. Weiden, MD
Stakeholder Perspective by Paul Anthony Polansky, BSPharm, MBA
Alzheimer's Disease: A Healthcare Burden of Epidemic Proportion
T.S. Dharmarajan, MD, FACP, AGSF
; Srinivas G. Gunturu, MD
Stakeholder Perspective by Jeff Januska, PharmD

Editorial

Healthcare Innovation Viability: On the Edge of a Knife
Robert E. Henry
Why Financial Incentives Aren't Enough to Move the Needle on Compliance
Emily Cox, PhD

Generic Drug Trends

Recent Slowdown in National Health Expenditures Attributed to Growing Use of Generics
Dalia Buffery, MA, ABD

Meeting Highlights

Cost-Sharing Strategies Decrease Adherence to Statin Therapy
Alice Goodman